4.5 Article

LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model

期刊

JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 136, 期 2, 页码 93-96

出版社

JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1016/j.jphs.2018.01.001

关键词

LPA5; Neuropathic pain; Multiple sclerosis

资金

  1. Ministry of Education, Culture, Sports, Science and Technology, Japan [26253077]
  2. Platform for Drug Discovery, Informatics, and Structural Life Science project - Japan Agency for Medical Research and Development [16am0101012j0005]
  3. Grants-in-Aid for Scientific Research [17K19918, 17K08287, 16K07093, 26860144, 17H01586, 26253077, 16H05136] Funding Source: KAKEN

向作者/读者索取更多资源

Lysophosphatidic acid (LPA) and LPA1 receptor signaling play a crucial role in the initiation of peripheral nerve injury-induced neuropathic pain through the alternation of pain-related genes/proteins expression and demyelination. However, LPA and its signaling in the brain are still poorly understood. In the present study, we revealed that the LPA5 receptor expression in corpus callosum elevated after the initiation of demyelination, and the hyperalgesia through A delta-fibers following cuprizone-induced demyelination was mediated by LPA5 signaling. These data suggest that LPA5 signaling may play a key role in the mechanisms underlying neuropathic pain following demyelination in the brain. (c) 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据